Aspirin as adjuvant therapy for colorectal cancer: a promising new twist for an old drug.
Neugut
Alfred I
AI
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality* / Q000473:pathology; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008019:Life Style; D009367:Neoplasm Staging; D015854:Up-Regulation
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D016861:Cyclooxygenase Inhibitors; D051546:Cyclooxygenase 2; D001241:Aspirin